bcl-2 Expression and prognosis in squamous-cell carcinomas of the esophagus

International Journal of Cancer

Volumn 69, Issue 4, 1996, Pages 324-328

  Sarbia, Mario ^a   Bittinger, Fernando ^b   Porschen, Rainer ^c   Verreet, Patrick ^a   Dutkowski, Philipp ^b   Willers, Reinhart ^a   Gabbert, Helmut E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION; HUMANS; MIDDLE AGED; MUCOUS MEMBRANE; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SURVIVAL RATE;

EID: 0029821811     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960822)69:4<324::AID-IJC15>3.0.CO;2-5     Document Type: Article

References (26)

1. AISENBERG, A.C., WILKES, B.M. and JACOBSON, J.O., The bcl-2 gene is rearranged in many diffuse B-cell lymphomas. Blood, 71, 969-972 (1988).
2. BRONNER, M.P., CULIN, C, REED, J.C. and FURTH, E.E., The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Amer J. Pathol., 146, 20-26 (1995).
3. CLEARY, M.L. and SKLAR, J., Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphomas and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc. nat. Acad. Sci. (Wash.), 82, 7439-7443 (1985).
4. COLOMBEL, M., SYMMANS, F., GIL, S., O'TOOLE, K.M., CHOPIN, D., BENSON, M., OLSSON, C.A., KORSMEYER, S. and BUTTYAN, R., Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Amer. J. Pathol., 143, 390-400 (1993).
5. HENRIKSEN, R., WILANDER, E. and ÖBERG, K., Expression and prognostic significance of bcl-2 in ovarian tumours. Brit. J. Cancer, 72, 1324-1329 (1995).
6. HERMANEK, P. and SOBIN, L.H. (eds.), TNM classification of malignant tumours (4th ed., 2nd rev.), Springer, Berlin (1992).
7. HOCKENBERY, D.M., ZUTTER, M., MICKEY, W., NAHM, M. and KORSMEYER, S.J., BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. not. Acad. Sci. (Wash.), 88, 6961-6965 (1991).
8. HSU, S.M., RAINE, L. and FANGER, H., Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29, 577-580 (1981).
9. JOENSUU, H., PYLKANEN, L. and TOIKKANEN, S., Bcl-2-protein expression and long-term survival in breast cancer. Amer. J. Pathol., 145, 1191-1198 (1994).
10. LAUWERS, G.Y., SCOTT, G.V. and HENDRICKS, J., Immunohistochemical evidence of aberrant bcl-2-protein expression in gastric epithelial dysplasia. Cancer, 73, 2900-2904 (1994).
11. LEEK, R.D., KAKLAMANIS, L., PEZZELLA, F., GATTER, K.C. and HARRIS, A.D., bcl-2 in normal human breast and carcinoma, association with oestrogen-receptor-positive, epidermal-growth-factor-negative tumours and in situ cancer. Brit. J. Cancer, 69, 135-139 (1994).
12. MCDONNELL, T.J. and KORSMEYER, S.J., Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature (Lond.), 349, 254-256 (1991).
13. NATHAN, B., ANBAZHAGAN, R., DYER, R., EBBS, M., JAYATILAKE, H. and GUSTERSON, B., Expression of bcl-2-like immunoreactivity in the normal breast and in breast cancer. Breast, 2, 134-137 (1993).
14. NATHARAJ, A., PATHAK, S., HOPWOOD, V.L., MCDONNEL, T.J. and ANANTHASWAMY, H.N., bcl-2 blocks differentiation and extends viability but does not immortalize normal human keratinocytes. Int. J. Oncol., 4, 1211-1218 (1994).
15. ÖFNER, D., RIEHEMANN, K., MAIER, H., RIEDMANN, B., NEHODA, H., T ÖTSCH, M., BÖCKER, W., JASANI, B. and SCHMID, K.W., Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survival. Brit. J. Cancer, 72, 981-985 (1995).
16. PEZZELLA, F., TURLEY, H., KUZU, I., TUNGEKAR, M.H., DUNNILL, M.S., PIERCE, C.B., HARRIS, A., GATTER, K.C. and MASON, D.Y., bcl-2 protein in non-small-cell lung carcinoma. New Engl. J. Med., 329, 690-694 (1993).
17. REED, J.C., CUDDY, M., SLABIAK, T., CROCE, C.M. and NOOWELL, P.C., Oncogenic potential of bcl-2 demonstrated by gene transfer. Nature (Lond.), 336, 259-261 (1988).
18. RITTER, J.H., DRESLER, C.M. and WICK, M.R., Expression of bcl-2 protein in stage T1N0M0 non-small-cell lung carcinoma. Hum. Pathol., 26, 1227-1232 (1995).
19. SAEGUSA, M., TAKANO, Y., HASHIMURA, M., SHOJI, Y. and OKAYASU, I., The possible role of bcl-2 expression in the progression of tumors of the uterine cervix. Cancer, 76, 2297-2303 (1995).
20. SILVESTRINI, R., VENERONI, S., DAIDONE, M.G., BENINI, E., BORACCHI, P., MEZZETTI, M., DI FRONZO, G., RILKE, F. and VERONESI, U., The bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph-node-negative breast-cancer patients. J. not. Cancer Inst., 86, 499-504 (1994).
21. SINICROPE, F.A., HART, J., MICHELASSI, F. and LEE, J.J., Prognostic value of bcl-2-oncoprotein expression in stage-II colon carcinoma. Clin. Cancer Res., 1, 1103-1110 (1995a).
22. SINICROPE, F.A., RUAN, S.B., CLEARY, K.R., STEPHENS, C., LEE, J.J. and LEVIN, B., bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res., 55, 237-241 (1995b).
23. SUCKOW, E.E., YOKOO, H. and BROCK, D.R., Intra-epithelial carcinoma concomitant with esophageal carcinoma. Cancer, 15, 733-740 (1962).
24. TSUJIMOTO, Y., GORHAM, J., COSSMAN, J., JAFFE, E. and CROCE, CM., The t(14;18)-chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science, 229, 1390-1393 (1985).
25. VERHAEGH, M.E.J.M., SANDERS, C.J.G., ARENDS, J.W. and NEUMANN, H.A.M., Expression of the apoptosis-suppressing protein bcl-2 in non-melanoma skin cancer. Brit. J. Dermatol., 132, 740-744 (1995).
26. WORLD HEALTH ORGANIZATION, Histological typing of oesphageal and gastric tumours (2nd ed.), Springer, Berlin (1990).